𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A pilot trial of propranolol for disruptive agitation in Alzheimer's disease

✍ Scribed by Peskind, Elaine R.; Tsuang, Debby W.; Kiyasu, Elizabeth; Eugenio, Charisma; Rein, Rebekah J.; Pascualy, Marcella; Raskind, Murray A.


Book ID
122921236
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
195 KB
Volume
21
Category
Article
ISSN
0197-4580

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A 6-month, randomized, double-blind, pla
✍ D.P. Devanand; Gregory H. Pelton; Karine Cunqueiro; Harold A. Sackeim; Karen Mar πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 215 KB πŸ‘ 2 views

## Abstract ## Objective In patients with Alzheimer's disease (AD) with psychosis or agitation that respond to haloperidol treatment, to evaluate the risk of relapse following discontinuation. ## Methods In outpatients with AD with symptoms of psychosis or agitation, responders to 20 weeks of ha